HomeCompareOBDCF vs JNJ

OBDCF vs JNJ: Dividend Comparison 2026

OBDCF yields 886.92% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBDCF wins by $1.11M in total portfolio value
10 years
OBDCF
OBDCF
● Live price
886.92%
Share price
$0.23
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.14M
Annual income
$4,984.35
Full OBDCF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — OBDCF vs JNJ

📍 OBDCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBDCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBDCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBDCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBDCF
Annual income on $10K today (after 15% tax)
$75,388.03/yr
After 10yr DRIP, annual income (after tax)
$4,236.70/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, OBDCF beats the other by $199.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBDCF + JNJ for your $10,000?

OBDCF: 50%JNJ: 50%
100% JNJ50/50100% OBDCF
Portfolio after 10yr
$583.7K
Annual income
$4,867.11/yr
Blended yield
0.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OBDCF
No analyst data
Altman Z
12.8
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBDCF buys
0
JNJ buys
0
No recent congressional trades found for OBDCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBDCFJNJ
Forward yield886.92%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28%
Portfolio after 10y$1.14M$30.5K
Annual income after 10y$4,984.35$4,749.88
Total dividends collected$738.2K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OBDCF vs JNJ ($10,000, DRIP)

YearOBDCF PortfolioOBDCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$55,046$44,345.90$10,594$274.49+$44.5KOBDCF
2$172,967$114,068.21$11,294$360.69+$161.7KOBDCF
3$352,565$167,490.42$12,133$476.91+$340.4KOBDCF
4$536,779$159,533.50$13,156$635.42+$523.6KOBDCF
5$687,852$113,499.38$14,432$854.61+$673.4KOBDCF
6$803,966$67,964.15$16,056$1,162.76+$787.9KOBDCF
7$897,364$37,120.06$18,175$1,604.53+$879.2KOBDCF
8$979,540$19,360.90$21,009$2,252.68+$958.5KOBDCF
9$1,057,984$9,875.65$24,911$3,229.73+$1.03MOBDCF
10$1,137,027$4,984.35$30,458$4,749.88+$1.11MOBDCF

OBDCF vs JNJ: Complete Analysis 2026

OBDCFStock

Obducat AB (publ) develops and supplies lithography solutions for the use in the production and replication of micro and nano structures worldwide. It offers EITRE, a semi-automated nanoimprint lithography for research and development purposes; SINDRE, a fully automated nanoimprint lithography system for high-volume manufacturing; EITRE Large Substrates, a semi-automated nanoimprint lithography tool for large substrates; and SINDRE Litho Track, a fully integrated nanoimprint lithography system. The company also provides installation, upgradation, remote support, and other support services. Its products are used in various markets, such as optical and photonic devices; LEDs and displays; MEMS and sensor devices; and bio and medical devices. Obducat AB (publ) was founded in 1989 and is headquartered in Lund, Sweden.

Full OBDCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this OBDCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBDCF vs SCHDOBDCF vs JEPIOBDCF vs OOBDCF vs KOOBDCF vs MAINOBDCF vs ABBVOBDCF vs MRKOBDCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.